The only probiotics with scientific evidence in infantile colic

Pharma Ace also represents BioGaia of Sweden – clinically proven Probiotics renowned for its human Lactobacillus reuteri strain for gut and immune health. Their benefits and safety in use for all ages is documented and supported by series of scientific studies and clinical studies.

BioGaia Drop especially is renowned as the only clinically proven probiotics that can prevent infantile colic. Other benefits include management of regurgitation, constipation, functional abdominal pain, acute gastroenteritis and, support of gastrointestinal health and management of antibiotic- associated side-effects. On adults its benefits on colonisation and effects on the immune system, benefits on gastrointestinal disorders and its safety aspects is well documented.

Their benefits and safety in use for all ages is documented and supported by series of scientific and clinical studies. To date 229 clinical studies have been conducted on almost 18,536 individuals whereof 71 studies are on 0 – 3 years old in 8,302 subjects. The results are published in 90 articles in scientific journals.

World leader in probiotics

BioGaia is a world leader in probiotics thanks to over 20 years experience in the field of probiotics. Over the years BioGaia have created a global network of leading, independent researchers and specialists, in-house experts and commercial partners worldwide.

Organisation

Headquarters, with executive management, administrative functions and marketing and sales are based in Stockholm. Product development and departments for production and quality control are based in Lund. Research, quality control and product development are also perused in Raleigh, North Carolina, USA. Sales offices are also based in Hiroshima and Shanghai.

The class B share of BioGaia is quoted on the Mid Cap list of the Nordic Exchange Stockholm.